IDEXX Laboratories Inc. Stock Advances 9.0%, Outperforms Competitors

Dow Jones
May 02

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of IDEXX Laboratories Inc. advanced 9.0% to $471.38 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.6% to 5,604.14 and the Dow Jones Industrial Average rising 0.2% to 40,752.96.

IDEXX Laboratories Inc. closed 14.1% short of its 52-week high of $548.88, which the company achieved on May 15th.

The stock outperformed some of its competitors, as Johnson & Johnson fell 1.2% to $154.46, Medtronic PLC fell 1.4% to $83.56, and Boston Scientific Corp. rose 0.31% to $103.19.

Trading volume totaled 1.4 million, compared to the 50-day average of 890,682.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 01, 2025 16:32 ET (20:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10